Edward M. Md Kaye
Director at Cytokinetics Inc (CYTK); Director at Stoke Therapeutics, Inc. (STOK)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $6.0M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Aug 18SEC | STOKStoke Therapeutics, Inc. | Sell | 11,930125,194 held (−9%) | $32.01 | $382K | -22.7% |
| Aug 18SEC | STOKStoke Therapeutics, Inc. | Sell | 637124,557 held (−1%) | $32.47 | $21K | -23.8% |
| Jun 1SEC | CYTKCytokinetics Inc | Sell Plan | 2,93310,283 held (−22%) | $76.09 | $223K | -17.3% |
| Dec 10SEC | STOKStoke Therapeutics, Inc. | Sell Plan | 3,82558,729 held (−6%) | $31.44 | $120K | -21.3% |
| Dec 10SEC | STOKStoke Therapeutics, Inc. | Sell Plan | 8,27450,455 held (−14%) | $32.52 | $269K | -23.9% |
| Dec 10SEC | STOKStoke Therapeutics, Inc. | Sell Plan | 1,33149,124 held (−3%) | $33.10 | $44K | -25.3% |
| Dec 5SEC | STOKStoke Therapeutics, Inc. | Sell Plan | 5,22272,333 held (−7%) | $30.76 | $161K | -19.6% |
| Dec 5SEC | STOKStoke Therapeutics, Inc. | Sell Plan | 1,23171,102 held (−2%) | $31.32 | $39K | -21.0% |
| Dec 5SEC | STOKStoke Therapeutics, Inc. | Sell Plan | 6,36764,735 held (−9%) | $31.33 | $199K | -21.0% |
| Dec 5SEC | STOKStoke Therapeutics, Inc. | Sell Plan | 1,68163,054 held (−3%) | $31.15 | $52K | -20.6% |
| Dec 5SEC | STOKStoke Therapeutics, Inc. | Sell Plan | 50062,554 held (−1%) | $31.85 | $16K | -22.3% |
| Dec 3SEC | STOKStoke Therapeutics, Inc. | Sell | 66152,780 held (−1%) | $29.56 | $20K | -16.3% |
| Dec 3SEC | STOKStoke Therapeutics, Inc. | Sell | 40552,375 held (−1%) | $30.14 | $12K | -17.9% |
| Dec 3SEC | STOKStoke Therapeutics, Inc. | Sell | 41951,956 held (−1%) | $30.34 | $13K | -18.5% |
| Dec 3SEC | STOKStoke Therapeutics, Inc. | Sell | 65151,305 held (−1%) | $30.85 | $20K | -19.8% |
| Dec 2SEC | CYTKCytokinetics Inc | Sell Plan | 28,0649,977 held (−74%) | $66.72 | $1.9M | -5.7% |
| Nov 12SEC | CYTKCytokinetics Inc | Sell Plan | 5,1759,977 held (−34%) | $65.08 | $337K | -3.3% |
| Oct 10SEC | STOKStoke Therapeutics, Inc. | Sell Plan | 25,00049,124 held (−34%) | $30.00 | $750K | -17.5% |
| Oct 7SEC | STOKStoke Therapeutics, Inc. | Sell Plan | 42,46149,124 held (−46%) | $25.09 | $1.1M | -1.4% |
| Oct 6SEC | CYTKCytokinetics Inc | Sell Plan | 6,7579,778 held (−41%) | $60.00 | $405K | +4.8% |
- Sell
Director Edward M. Md Kaye sold $223K of CYTK at $76.09 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Edward M. Md Kaye sold $120K of STOK at $31.44 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Edward M. Md Kaye sold $269K of STOK at $32.52 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Edward M. Md Kaye sold $44K of STOK at $33.10 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Edward M. Md Kaye sold $161K of STOK at $30.76 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Edward M. Md Kaye sold $39K of STOK at $31.32 — pre-scheduled 10b5-1 plan sale.